logo
Select company
Select metric
$ 16.28MDepreciation, Amortization & Accretion
VS
Market
46
Sector
75
Industry
92
History
33
$ 17.38Close
$ 7.8 - $ 29.6 52-Week Range
Ticker Information

Ticker

LYEL

Company Name

LYELL IMMUNOPHARMA INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

LYELL IMMUNOPHARMA INC - Depreciation, Amortization & Accretion Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

LYEL - DepAmor Historical data
DateDepreciation, Amortization & Accretion
6/30/2025$ 16.28M
3/31/2025$ 18.05M
12/31/2024$ 19.63M
9/30/2024$ 19.66M
6/30/2024$ 20.09M
3/31/2024$ 20.25M
12/31/2023$ 20.25M
9/30/2023$ 21.34M
6/30/2023$ 19.75M
3/31/2023$ 18.86M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • LYELL IMMUNOPHARMA INC's latest trailing twelve months (TTM) DepAmor stands at $ 4.29M.
  • Over the past 5 years, LYELL IMMUNOPHARMA INC's average DepAmor has been $ 17.19M.
  • The median DepAmor for LYELL IMMUNOPHARMA INC during this period was $ 18.45M
  • LYELL IMMUNOPHARMA INC reached its highest DepAmor over the past 5 years at $ 21.34M.
  • The lowest DepAmor recorded by LYELL IMMUNOPHARMA INC in the same timeframe $ 4.29M

LYELL IMMUNOPHARMA INC's DepAmor vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

DepAmor Benchmarks
CompanyDepAmor
FDMT : 4D MOLECULAR THERAPEUTICS INC $ 7.13MINMB : INMUNE BIO INC $ 0HYPD : HYPERION DEFI INC $ 736.5KEPRX : EUPRAXIA PHARMACEUTICALS INC $ 194.19KVOR : VOR BIOPHARMA INC $ 12.62MTVGN : TEVOGEN BIO HOLDINGS INC $ 601.47KCRGX : CARGO THERAPEUTICS INC $ 4.94MCURX : CURANEX PHARMACEUTICALS INC -MNPR : MONOPAR THERAPEUTICS $ 0TIL : INSTIL BIO INC $ 2.34M

Definition of Depreciation, Amortization & Accretion

[Cash Flow Statement] A component of operating cash flow [NCFO] representing the aggregate net amount of depreciation, amortization, and accretion recognized during an accounting period. As a non-cash item, the net amount is added back to net income when calculating cash provided by operations.

LYEL - Depreciation, Amortization & Accretion, Last 5 years

$ 4.29M

Minimum

Dec 31, 2020

$ 21.34M

Maximum

Sep 30, 2023

$ 17.19M

Average

$ 18.45M

Median

DepAmor Benchmark Analysis

The chart above depicts the distribution of DepAmor for companies in the Total Stock Market. The average DepAmor of the companies is $ 24.07M with a standard deviation of $ 33.58M.
The following table provides additional summary stats:
DepAmor in the Market:
filtered constituents3.16K
min$ -81M
max$ 135.97M
average$ 24.07M
median$ 6.83M
std$ 33.58M